Ameritas Investment Partners’s Alaunos Therapeutics TCRT Stock Holding History

Ameritas Investment Partners’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-126	Closed	-$12K	–	3228
2022 Q1	$12K	Hold	126	–	–	﹤0.01%	2745
2021 Q4	$21K	Hold	126	–	–	﹤0.01%	2628
2021 Q3	$34K	Hold	126	–	–	﹤0.01%	2398
2021 Q2	$50K	Hold	126	–	–	﹤0.01%	2188
2021 Q1	$68K	Hold	126	–	–	﹤0.01%	1896
2020 Q4	$47K	Hold	126	–	–	﹤0.01%	2025
2020 Q3	$47K	Hold	126	–	–	﹤0.01%	1881
2020 Q2	$62K	Buy	126 +35	+38%	+$15.6K	﹤0.01%	1704
2020 Q1	$34K	Hold	91	–	–	﹤0.01%	1880
2019 Q4	$65K	Hold	91	–	–	﹤0.01%	1761
2019 Q3	$59K	Hold	91	–	–	﹤0.01%	1789
2019 Q2	$80K	Buy	91 +18	+25%	+$12.4K	﹤0.01%	1645
2019 Q1	$42K	Hold	73	–	–	﹤0.01%	1986
2018 Q4	$21K	Hold	73	–	–	﹤0.01%	2315
2018 Q3	$35K	Hold	73	–	–	﹤0.01%	2191
2018 Q2	$33K	Buy	73 +3	+4%	+$1.9K	﹤0.01%	2235
2018 Q1	$41K	Hold	70	–	–	﹤0.01%	2028
2017 Q4	$43K	Hold	70	–	–	﹤0.01%	2009
2017 Q3	$67K	Hold	70	–	–	﹤0.01%	1697
2017 Q2	$65K	Hold	70	–	–	﹤0.01%	1731
2017 Q1	$67K	Hold	70	–	–	﹤0.01%	1656
2016 Q4	$56K	Hold	70	–	–	﹤0.01%	1111
2016 Q3	$59K	Buy	+70	New	+$56.3K	﹤0.01%	1094

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameritas Investment Partners's TCRT Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 126 shares — an estimated $12K sold.

Ameritas Investment Partners first reported a position in TCRT in Q3 2016 and held it in 23 quarters. The position peaked at $80K in Q2 2019. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

Ameritas Investment Partners reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 126 Alaunos Therapeutics shares in Q2 2022, an estimated $12K.
Ameritas Investment Partners first reported a position in Alaunos Therapeutics in Q3 2016 and held it in 23 quarters.
Ameritas Investment Partners's Alaunos Therapeutics position peaked at $80K in Q2 2019.
124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.